Abbott Laboratories - ABT

Abbott Laboratories, stock ticker ABT, pays a 48 cent dividend, which is currently a 3.52% dividend yield! As of December 9th, 2011 ABT has declared 352 consecutive quarterly dividends. Now if that isn't stability I'm not quite sure what is. ABT continues to create products which improve and prolong our lives.
They are engaged in discovery, development, manufacture, and sale of diversified line of health care products. Their pharmaceutical products include a line of adult and pediatric pharmaceuticals manufactured, marketed, and sold directly to wholesalers and health care facilities ABT's diagnostic products include a line of diagnostic systems and tests manufactured, marketed, and sold to hospitals and commercial laboratories. Their nutritional products, which include a line of pediatric and adult nutritional products. Their vascular products include a line of coronary, endovascular, and vessel closure devices for the treatment of vascular disease.
On February 15, 2010, it acquired the Solvay Group's pharmaceuticals business. In March 2010, it acquired Starlims Technologies Limited. In April 2010, it acquired Facet Biotech Corporation. On September 8, 2010, it acquired Piramal Health care Limited’s Health care Solutions business.
Stash your money into this winner and fa-get-about it! In short, baby boomers will contribute to health care industry in a major way over the next 20 to 30 years. ABT is currently selling at 10 times earnings, they pay a solid dividend each quarter, have raised their dividend each quarter for the past 40 yrs, and they are projected to grow earnings per share 11% per year for the next 5 years!
Visit Abbott's home page, here, and their Investor Relations website, here. Thanks for your time.